{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:21Z","timestamp":1790697981169,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00259-023-06176-6","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T23:24:29Z","timestamp":1677885869000},"page":"2250-2257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT\/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting"],"prefix":"10.1007","volume":"50","author":[{"given":"Hong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heying","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina Mari","family":"Aparici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Davidzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Franc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagruti","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-5329","authenticated-orcid":false,"given":"Andrei","family":"Iagaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"6176_CR1","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1007\/s00259-019-04404-6","volume":"46","author":"O Israel","year":"2019","unstructured":"Israel O, Pellet O, Biassoni L, De Palma D, Estrada-Lobato E, Gnanasegaran G, et al. Two decades of SPECT\/CT - the coming of age of a technology: an updated review of literature evidence. Eur J Nucl Med Mol Imaging. 2019;46:1990\u20132012.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6176_CR2","volume-title":"Hybrid imaging: SPECT\/CT and PET\/CT: W.B","author":"SRS Cherry","year":"2012","unstructured":"Cherry SRS, James A, Phelps ME. Hybrid imaging: SPECT\/CT and PET\/CT: W.B: Saunders; 2012."},{"key":"6176_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.semnuclmed.2008.01.001","volume":"38","author":"Y Seo","year":"2008","unstructured":"Seo Y, Mari C, Hasegawa BH. Technological development and advances in single-photon emission computed tomography\/computed tomography. Semin Nucl Med. 2008;38:177\u201398.","journal-title":"Semin Nucl Med"},{"key":"6176_CR4","unstructured":"IAEA. IMAGINE - IAEA Medical imAGIng and Nuclear mEdicine global resources database\u00a0https:\/\/humanhealthiaeaorg\/HHW\/DBStatistics\/IMAGINEhtml.\u00a0Accessed 1 Oct 2022\u00a0"},{"key":"6176_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/pros.23919","volume":"80","author":"B Grubmuller","year":"2020","unstructured":"Grubmuller B, Rasul S, Baltzer P, Fajkovic H, D'Andrea D, Berndl F, et al. Response assessment using [(68) Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer. Prostate. 2020;80:74\u201382.","journal-title":"Prostate."},{"key":"6176_CR6","first-page":"1651","volume":"63","author":"A Gafita","year":"2022","unstructured":"Gafita A, Rauscher I, Weber M, Hadaschik B, Wang H, Armstrong WR, et al. Novel framework for treatment response evaluation using PSMA PET\/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study. J Nucl Med. 2022;63:1651\u20138.","journal-title":"J Nucl Med"},{"key":"6176_CR7","doi-asserted-by":"publisher","first-page":"20160402","DOI":"10.1259\/bjr.20160402","volume":"91","author":"M Ljungberg","year":"2018","unstructured":"Ljungberg M, Pretorius PH. SPECT\/CT: an update on technological developments and clinical applications. Br J Radiol. 2018;91:20160402.","journal-title":"Br J Radiol"},{"key":"6176_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1053\/j.semnuclmed.2022.01.004","volume":"52","author":"P Ritt","year":"2022","unstructured":"Ritt P. Recent developments in SPECT\/CT. Semin Nucl Med. 2022;52:276\u201385.","journal-title":"Semin Nucl Med"},{"key":"6176_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2967\/jnumed.108.060020","volume":"50","author":"SS Gambhir","year":"2009","unstructured":"Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, et al. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med. 2009;50:635\u201343.","journal-title":"J Nucl Med"},{"key":"6176_CR10","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s12350-018-1283-y","volume":"25","author":"S Dorbala","year":"2018","unstructured":"Dorbala S, Ananthasubramaniam K, Armstrong IS, Chareonthaitawee P, DePuey EG, Einstein AJ, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol. 2018;25:1784\u2013846.","journal-title":"J Nucl Cardiol"},{"key":"6176_CR11","unstructured":"Wacholz CH, Carrie ; OConnor, and Michael. Veriton multi-CZT detector SPECT\/CT system acceptance testing. J Nucl Med 2020;61:3003."},{"key":"6176_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40658-020-0284-5","volume":"7","author":"C Desmonts","year":"2020","unstructured":"Desmonts C, Bouthiba MA, Enilorac B, Nganoa C, Agostini D, Aide N. Evaluation of a new multipurpose whole-body CzT-based camera: comparison with a dual-head Anger camera and first clinical images. EJNMMI Phys. 2020;7:18.","journal-title":"EJNMMI Phys"},{"key":"6176_CR13","first-page":"1288","volume":"60","author":"L Imbert","year":"2019","unstructured":"Imbert L, Chevalier E, Claudin M, Karcher G, Verger A, Paycha F, Marie PY. A one-shot whole-body bone SPECT may be recorded in less than 20 minutes with the high-sensitivity Veriton\u00ae CZT-camera. J Nucl Med. 2019;60:1288.","journal-title":"J Nucl Med"},{"key":"6176_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385:1091\u2013103.","journal-title":"N Engl J Med"},{"key":"6176_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"J Strosberg","year":"2017","unstructured":"Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of (177) Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125\u201335.","journal-title":"N Engl J Med"},{"key":"6176_CR16","first-page":"12S","volume":"62","author":"G Sgouros","year":"2021","unstructured":"Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, et al. Tumor response to radiopharmaceutical therapies: the knowns and the unknowns. J Nucl Med. 2021;62:12S\u201322S.","journal-title":"J Nucl Med"},{"key":"6176_CR17","doi-asserted-by":"publisher","first-page":"60S","DOI":"10.2967\/jnumed.121.262977","volume":"62","author":"N Pandit-Taskar","year":"2021","unstructured":"Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, et al. Dosimetry in clinical radiopharmaceutical therapy of cancer: practicality versus perfection in current practice. J Nucl Med. 2021;62:60S\u201372S.","journal-title":"J Nucl Med"},{"key":"6176_CR18","unstructured":"GE Medical Systems Israel FI, GE Healthcare. FDA 510(k) premarket notification submission - StarGuide. https:\/\/www.accessdatafdagov\/cdrh_docs\/pdf21\/K210173pdf. 2021:5-6.\u00a0Accessed 1 Oct 2022"},{"key":"6176_CR19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2967\/jnumed.115.159301","volume":"56","author":"EJ Teoh","year":"2015","unstructured":"Teoh EJ, McGowan DR, Macpherson RE, Bradley KM, Gleeson FV. Phantom and Clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET\/CT system. J Nucl Med. 2015;56:1447\u201352.","journal-title":"J Nucl Med"},{"key":"6176_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"6176_CR21","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.7150\/thno.63860","volume":"11","author":"N Benabdallah","year":"2021","unstructured":"Benabdallah N, Scheve W, Dunn N, Silvestros D, Schelker P, Abou D, et al. Practical considerations for quantitative clinical SPECT\/CT imaging of alpha particle emitting radioisotopes. Theranostics. 2021;11:9721\u201337.","journal-title":"Theranostics."},{"key":"6176_CR22","doi-asserted-by":"publisher","first-page":"235029","DOI":"10.1088\/1361-6560\/aaef63","volume":"63","author":"PL Esquinas","year":"2018","unstructured":"Esquinas PL, Rodriguez-Rodriguez C, Esposito TVF, Harboe J, Bergamo M, Celler A, et al. Dual SPECT imaging of (111) In and (67) Ga to simultaneously determine in vivo the pharmacokinetics of different radiopharmaceuticals: a quantitative tool in pre-clinical research. Phys Med Biol. 2018;63:235029.","journal-title":"Phys Med Biol"},{"key":"6176_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4274\/Mirt.138","volume":"21","author":"YE Erdi","year":"2012","unstructured":"Erdi YE. Limits of tumor detectability in nuclear medicine and PET. Mol Imaging Radionucl Ther. 2012;21:23\u20138.","journal-title":"Mol Imaging Radionucl Ther"},{"key":"6176_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/acm2.13158","volume":"22","author":"T Ito","year":"2021","unstructured":"Ito T, Matsusaka Y, Onoguchi M, Ichikawa H, Okuda K, Shibutani T, et al. Experimental evaluation of the GE NM\/CT 870 CZT clinical SPECT system equipped with WEHR and MEHRS collimator. J Appl Clin Med Phys. 2021;22:165\u201377.","journal-title":"J Appl Clin Med Phys"},{"key":"6176_CR25","first-page":"853","volume":"38","author":"R Lebtahi","year":"1997","unstructured":"Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med. 1997;38:853\u20138.","journal-title":"J Nucl Med"},{"key":"6176_CR26","first-page":"1125","volume":"62","author":"G Le Rouzic","year":"2021","unstructured":"Le Rouzic G, Zananiri R. First performance measurements of a new multi-detector CZT-Based SPECT\/CT system: GE StarGuide. J Nucl Med. 2021;62:1125.","journal-title":"J Nucl Med"},{"key":"6176_CR27","doi-asserted-by":"publisher","first-page":"36S","DOI":"10.2967\/jnumed.121.262748","volume":"62","author":"C Uribe","year":"2021","unstructured":"Uribe C, Peterson A, Van B, Fedrigo R, Carlson J, Sunderland J, et al. An international study of factors affecting variability of dosimetry calculations, part 1: design and early results of the SNMMI dosimetry challenge. J Nucl Med. 2021;62:36S\u201347S.","journal-title":"J Nucl Med"},{"key":"6176_CR28","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.2967\/jnumed.121.262749","volume":"62","author":"J Capala","year":"2021","unstructured":"Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, et al. Dosimetry for radiopharmaceutical therapy: current practices and commercial resources. J Nucl Med. 2021;62:3S\u201311S.","journal-title":"J Nucl Med"},{"key":"6176_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2967\/jnumed.118.219352","volume":"60","author":"J Violet","year":"2019","unstructured":"Violet J, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, et al. Dosimetry of (177) Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes. J Nucl Med. 2019;60:517\u201323.","journal-title":"J Nucl Med"},{"key":"6176_CR30","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.18632\/oncotarget.12240","volume":"8","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Reinhardt S, Ilhan H, Delker A, Boning G, Gildehaus FJ, et al. Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer. Oncotarget. 2017;8:3581\u201390.","journal-title":"Oncotarget."},{"key":"6176_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2967\/jnumed.122.264398","volume":"64","author":"S Pathmanandavel","year":"2022","unstructured":"Pathmanandavel S, Crumbaker M, Ho B, Yam AO, Wilson P, Niman R, et al. Evaluation of (177) Lu-PSMA SPECT quantitation as a response biomarker within a prospective (177) Lu-PSMA-617 and NOX66 combination trial (LuPIN). J Nucl Med. 2022;64:221\u20136.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06176-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:02:22Z","timestamp":1686186142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06176-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["6176"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06176-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AI is an unpaid consultant to GE Healthcare. Hong Song, Valentina Ferri, Heying Duan, Carina Mari Aparici, Guido Davidzon, Benjamin L. Franc, Farshad Moradi, Judy Nguyen, and Jagruti Shah declare that they have no conflict or competing of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}